Phase 1b Study of Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve Subjects With Acute Myelogenous Leukemia
Phase of Trial: Phase I
Latest Information Update: 25 Jun 2019
Price : $35 *
At a glance
- Drugs Venetoclax (Primary) ; Cytarabine; Daunorubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 21 Jun 2019 Planned number of patients changed from 58 to 64.
- 26 Nov 2018 Status changed from not yet recruiting to recruiting.
- 25 Oct 2018 New trial record